Bionoid Pharma, Inc. has signed a Letter of Intent to acquire all the outstanding shares of Global Alerts Corp. The acquisition is expected to provide international growth opportunities for Bionoid Pharma. Global Alerts Corp. is focused on delivering a mass notification platform to the 6 billion population worldwide that currently do not have access to a mass emergency alert/ notification capability. The company has signed an exclusive license agreement with One World UPSEN Alliance, a non-profit corporation that is solely responsible for the delivery of the next generation of an automated global emergency mass messaging platform. Global Alerts has exclusive rights to design, support and maintain the UPSEN platform for the more than 6 billion people not currently covered by the existing alert systems.
Bionoid Pharma, Inc. (“BINP”) (OTC PINK:BINP) announced today that it has signed a Letter of Intent to acquire all the outstanding shares of Global Alerts Corp. (“Global Alerts”), a private company focused on delivering a singular mass notification platform to the 6 billion population around the globe that currently do not have access to a mass emergency alert/ notification capability.
“We’re excited to announce our proposed acquisition of Global Alerts Corp. and the international growth opportunities we believe it represents to BINP,” says Wayne Cockburn, CEO of Bionoid Pharma. “North Americans are quite familiar with Amber Alert, an emergency alert system distributed via commercial and public radio stations, Internet radio, satellite radio, television stations, wireless devices, e-mail, electronic traffic-condition signs, commercial electronic billboards, and cable TV by the Emergency Alert System and NOAA Weather Radios. Global Alerts has signed an exclusive license agreement with One World UPSEN Alliance, a non-profit corporation that is solely responsible for the delivery of the next generation of an automated global emergency mass messaging platform. Under the agreement with One World UPSEN Alliance, Global Alerts has exclusive rights to design, support and maintain the UPSEN platform for the more than 6 billion people not currently covered by the existing alert systems.”
Source: BioSpace
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
